{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:28:20Z","timestamp":1791599300435,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T00:00:00Z","timestamp":1487721600000},"content-version":"vor","delay-in-days":52,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.atherosclerosis.2016.11.010","type":"journal-article","created":{"date-parts":[[2016,11,11]],"date-time":"2016-11-11T12:47:09Z","timestamp":1478868429000},"page":"47-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":114,"special_numbering":"C","title":["Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: The EPIC-Norfolk prospective population study"],"prefix":"10.1016","volume":"256","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2395-2333","authenticated-orcid":false,"given":"Nicolas","family":"Perrot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutger","family":"Verbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjinder","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Matthijs","family":"Boekholdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Kees","family":"Hovingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Wareham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay-Tee","family":"Khaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit J.","family":"Arsenault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.atherosclerosis.2016.11.010_bib1","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2016.11.010_bib2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2016.11.010_bib3","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/ng.3396","article-title":"A\u00a0comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"Nikpay","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2016.11.010_bib4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2796.2012.02592.x","article-title":"Lipoprotein(a): resurrected by genetics","volume":"273","author":"Kronenberg","year":"2013","journal-title":"J.\u00a0Intern Med."},{"key":"10.1016\/j.atherosclerosis.2016.11.010_bib5","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCGENETICS.113.000400","article-title":"Lipoprotein(a) levels, genotype, and incident aortic valve stenosis: a prospective mendelian randomization study and replication in a case-control cohort","volume":"7","author":"Arsenault","year":"2014","journal-title":"Circ. Cardiovasc Genet."},{"key":"10.1016\/j.atherosclerosis.2016.11.010_bib6","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2016.11.010_bib7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1172\/JCI115855","article-title":"Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations","volume":"90","author":"Boerwinkle","year":"1992","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2016.11.010_bib8","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1194\/jlr.M800174-JLR200","article-title":"A\u00a0novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma","volume":"49","author":"Bergmark","year":"2008","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2016.11.010_bib9","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","article-title":"Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.11.010_bib10","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jacc.2014.06.1190","article-title":"Low-risk diet and lifestyle habits in the primary prevention of myocardial infarction in men: a population-based prospective cohort study","volume":"64","author":"Akesson","year":"2014","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.11.010_bib11","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jacc.2010.11.041","article-title":"Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence","volume":"57","author":"Folsom","year":"2011","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"16","key":"10.1016\/j.atherosclerosis.2016.11.010_bib12","first-page":"1690","article-title":"Ideal cardiovascular health and risk of cardiovascular events in the EPIC-Norfolk prospective population study","volume":"57","author":"Lachman","year":"2015","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"Suppl 1","key":"10.1016\/j.atherosclerosis.2016.11.010_bib13","first-page":"95","article-title":"EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer","volume":"80","author":"Day","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.atherosclerosis.2016.11.010_bib14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1079\/PHN2002439","article-title":"Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study","volume":"6","author":"Wareham","year":"2003","journal-title":"Public health Nutr."},{"key":"10.1016\/j.atherosclerosis.2016.11.010_bib15","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1161\/ATVBAHA.112.255521","article-title":"Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population study","volume":"32","author":"Gurdasani","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.11.010_bib16","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1161\/CIRCULATIONAHA.107.729939","article-title":"Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms","volume":"116","author":"Mora","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.11.010_bib17","doi-asserted-by":"crossref","first-page":"e0132959","DOI":"10.1371\/journal.pone.0132959","article-title":"Associations of low-intensity resistance training with body composition and lipid profile in obese patients with type 2 diabetes","volume":"10","author":"Hamasaki","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2016.11.010_bib18","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s12020-012-9650-y","article-title":"The effects of resistance training on ApoB\/ApoA-I ratio, Lp(a) and inflammatory markers in patients with type 2 diabetes","volume":"42","author":"Kadoglou","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.atherosclerosis.2016.11.010_bib19","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1194\/jlr.M005769","article-title":"Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet","volume":"51","author":"Faghihnia","year":"2010","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2016.11.010_bib20","doi-asserted-by":"crossref","first-page":"e114859","DOI":"10.1371\/journal.pone.0114859","article-title":"Healthy dietary interventions and lipoprotein (a) plasma levels: results from the Omni Heart Trial","volume":"9","author":"Haring","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2016.11.010_bib21","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1161\/01.CIR.0000028421.91733.20","article-title":"Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: a randomized, controlled, crossover trial","volume":"106","author":"Jenkins","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.11.010_bib22","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0026-0495(03)00260-9","article-title":"The effect of combining plant sterols, soy protein, viscous fibers, and almonds in treating hypercholesterolemia","volume":"52","author":"Jenkins","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2016.11.010_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.nut.2007.09.003","article-title":"Flaxseed on cardiovascular disease markers in healthy menopausal women: a randomized, double-blind, placebo-controlled trial","volume":"24","author":"Dodin","year":"2008","journal-title":"Nutrition"},{"key":"10.1016\/j.atherosclerosis.2016.11.010_bib24","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jacc.2015.07.020","article-title":"Oxidized Phospholipids, Lipoprotein(a), and Progression of calcific aortic valve stenosis","volume":"66","author":"Capoulade","year":"2015","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.11.010_bib25","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.jacc.2009.02.041","volume":"53","author":"Fraley","year":"2009","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.11.010_bib26","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jacc.2008.02.066","article-title":"Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study","volume":"52","author":"Choi","year":"2008","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.11.010_bib27","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jacc.2014.03.061","article-title":"Discrimination and net reclassification of cardiovascular risk with lipoprotein(a): prospective 15-year outcomes in the Bruneck Study","volume":"64","author":"Willeit","year":"2014","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.11.010_bib28","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jacc.2012.12.023","article-title":"Extreme lipoprotein(a) levels and improved cardiovascular risk prediction","volume":"61","author":"Kamstrup","year":"2013","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2016.11.010_bib29","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1194\/jlr.R053066","article-title":"Current therapies for lowering lipoprotein(a)","volume":"57","author":"van Capelleveen","year":"2015","journal-title":"J.\u00a0Lipid Res."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016314782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016314782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T16:21:10Z","timestamp":1536250870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915016314782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":29,"alternative-id":["S0021915016314782"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.11.010","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: The EPIC-Norfolk prospective population study","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}